Company Filing History:
2 out of 1,745 
2 out of 109 
2 out of 24 Years Active: 2017-2018
Title: **Vincent Oustric: A Pioneer in Erythropoietic Protoporphyria Treatment**
Introduction
Vincent Oustric is an innovative inventor based in Paris, France. He has contributed significantly to the field of medical science with a focus on treating rare genetic conditions, notably Erythropoietic Protoporphyria. With a total of two patents to his name, Oustric's work reflects a dedication to advancing therapeutic methods that can improve patient health outcomes.
Latest Patents
Oustric's latest inventions pertain to methods and pharmaceutical compositions for the treatment of Erythropoietic Protoporphyria. These inventions specifically involve a method for increasing the amount of functional FECH in erythroid cells carrying the hypomorphic allele IVS3 48C/T (rs2272783) alongside a deleterious mutation in the FECH gene. The approach consists of introducing at least one antisense oligonucleotide (ASO), which is designed to prevent the splicing of the cryptic exon inserted into the mutant IVS3 48C/T (rs2272783) FECH mRNA. This innovative method has the potential to provide solutions for individuals afflicted by this condition.
Career Highlights
Vincent Oustric has collaborated with prestigious institutions, including the Institut National de la Santé et de la Recherche Médicale and Université Paris Diderot - Paris 7. His extensive research in these institutions has reinforced his standing in the field of medical innovation, particularly concerning genetic disorders affecting erythropoiesis.
Collaborations
Throughout his career, Oustric has worked alongside notable colleagues such as Laurent Gouya and Jean-Charles Deybach. These collaborations have played a pivotal role in advancing the understanding and treatment of Erythropoietic Protoporphyria, underscoring the importance of teamwork in scientific discovery and innovation.
Conclusion
With his groundbreaking patents and collaborative efforts, Vincent Oustric has emerged as a key figure in the treatment of Erythropoietic Protoporphyria. His contributions not only reflect his expertise as an inventor but also highlight the vital role of innovation in addressing complex medical challenges. As research continues, Oustric's work may pave the way for further advancements in this important area of healthcare.